Executive Vice President and Chief Commercial Officer · ABIOMED INC (ABMD)

Andrew Greenfield

A named executive officer of ABIOMED in every fiscal year CompBrief holds from FY2020 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$2,836,043

Salary $345,340Stock awards $1,737,360

FY2021: $4,026,067

3rd of 5 named executive officers at Abiomed by FY2022 total.

5 named officers on file for ABIOMED, FY2022

Andrew Greenfield’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • ABMD’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ABIOMED’s whole pay program stands against its peers

  • ABIOMED’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ABMD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed June 28, 2022 (DEF 14A).

Free

Get Andrew Greenfield’s full pay file as a PDF — free

More than this page: up to 10 years of Andrew’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Andrew Greenfield compensation by year

ABIOMED Summary Compensation Table · all 3 fiscal years held
In US dollars, as ABIOMED reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022
Salary$336,507$301,454$345,340
Bonus$0$0$0
Stock awards$1,598,340$3,010,116$1,737,360
Option awards$673,878$377,276$293,737
Non-equity incentive$201,904$328,095$450,366
Pension and deferred compensation$0$0$0
All other$8,976$9,126$9,240
Total$2,819,605$4,026,067$2,836,043

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ABIOMED INC DEF 14A filed June 28, 2022, accession 0001193125-22-183958, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ABIOMED INC filed document, accession 0001193125-22-183958. Every figure is read from that document and cited to the page and table it appears in. Filed June 28, 2022.

$2.8M
$4.0M
$2.8M
FY20
FY21
FY22
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
PSU8,300$2,749,292—
RSU7,139$2,364,722—
Option2,868—$283.88
Option2,334—$266.39
Option3,264—$223.90

Per the Outstanding Equity Awards at Fiscal Year-End table in ABIOMED INC's FY2022 proxy; value at the fiscal year-end close, as the company printed it.

ABIOMED’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Michael MinogueChairman of the Board, President, Chief Executive Officer$12,665,992
Todd TrappExecutive Vice President, Chief Financial Officer$3,040,990
Andrew Greenfield · this pageExecutive Vice President and Chief Commercial Officer$2,836,043
Marc BeganExecutive Vice President, General Counsel$2,566,862
David WeberFormer Senior Vice President and Chief Operating Officer$2,287,238

The full ABIOMED compensation record

free company brief

This page is one person within ABIOMED's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the ABIOMED proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ABIOMED's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Andrew Greenfield's compensation dossier · One-time report. No refunds.